Increasingly, heart disease and blood vessels occur in people at a young age. Increased blood pressure, arrhythmias and conduction, congenital and acquired heart defects require timely correction. Without treatment, heart disease quickly lead to deterioration of General health, a significant limitation of physical activity, affect the duration of human life in General. To obtain great outcomes with the least amount of time possible in the clinic, which has excellent diagnostic equipment and trusts work with patients only experienced doctors.
In Israel cardiac assistance is organized at a high level, because you can fully tested and get the results of laboratory and instrumental tests in 2-3 days.
To diagnose apply:
If necessary can be used in clinical tests, such as General and biochemical blood tests, urine analysis, x-ray of the chest. Also apply specific tests, the purpose of which may be the identification of systemic connective tissue diseases and other disorders that can affect the health of the heart and blood vessels.
Diseases of the cardiovascular system is heterogeneous in nature. Because in some cases, time started the medication relieves the patient from the need in the future to go for surgery and suffer from complications. In other cases, timely surgery can relieve the patient from the need for life to take pills and to observe any restrictions. To understand what tactics are preferred in each case, can an experienced cardiologist.
At the discretion of the physician, the patient may receive:
Options for surgical treatment:
The Israeli clinics doctors use international standards and treatment protocols. It is a guarantee that you will be able to obtain the necessary assistance. An example of the innovations that are already widely used by the Israeli surgeons, technology is a replacement of the aortic valve through the femoral artery. This operation does not require the conduct extensive incision and opening the chest, because it is much easier tolerated by patients of all ages.
A therapy that uses bone-marrow stem cells to promote heart repair did not significantly improve the primary outcome over a sham procedure among patients with congestive heart failure. However, it revealed critical new insights, according to investigators of the CHART-1 trial.
An alternative to heart transplantation could one day be in the cards for patients with heart failure; scientists have created a "bionic heart patch" that allows doctors to remotely deliver tissue regeneration drugs to patients in real-time.